Reducing cancer treatment to improve quality of life without lowering effectiveness, and death rates are climbing for certain cancers in Hispanic Americans.

by Kevin McLaughlin

Childhood cancer survivors have a higher risk of developing depression and anxiety, and study links polycystic ovary syndrome to higher ovarian cancer risk for postmenopausal women.

by Thomas Celona

New treatments have changed care for multiple myeloma, and as drug companies have moved away from producing generics, the U.S. runs into cancer drug shortages.

by Eric Fitzsimmons

Women diagnosed with early-stage breast cancer are more likely to live five years or longer compared with those diagnosed in earlier decades, and reports of functional limitations increase among cancer survivors.

by Marci A. Landsmann

Daily pill lowers lung cancer death rate, and FDA authorizes importing shortage-affected cancer drugs from China.

by Kevin McLaughlin

Minimally invasive surgery found to be effective for pancreatic cancer patients, and drug shortages begin to impact some cancer treatments.

by Thomas Celona

High cancer death rates in Native Hawaiian and Pacific Islander communities, and thousands of people lose Medicaid for procedural reasons.

by Eric Fitzsimmons

Cancer drugs are affected by shortages, and angiogenesis inhibitors make a comeback in combination treatments.

by Kevin McLaughlin

Mammography screening recommendation pushed back to age 40, and pancreatic cancer vaccine shows promising immune response.

by Marci A. Landsmann

Researchers discover a new way breast density can impact cancer risk, and CAR T-cell therapy remains out of reach for patients with HIV.

by Thomas Celona